DE2218162A1 - Entzündungshemmende Mittel - Google Patents

Entzündungshemmende Mittel

Info

Publication number
DE2218162A1
DE2218162A1 DE19722218162 DE2218162A DE2218162A1 DE 2218162 A1 DE2218162 A1 DE 2218162A1 DE 19722218162 DE19722218162 DE 19722218162 DE 2218162 A DE2218162 A DE 2218162A DE 2218162 A1 DE2218162 A1 DE 2218162A1
Authority
DE
Germany
Prior art keywords
protease
cellulose
group
proteases
molecular weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19722218162
Other languages
German (de)
English (en)
Inventor
Setsuro Dr.med. ToVaishima; Otsuka Masatomi Naruto Tokushima; Osaki Yoshiyasu Ishii Miyozai Tokushima; Fujii (Japan). P
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Kagaku Yakuhin KK
Original Assignee
Otsuka Kagaku Yakuhin KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Kagaku Yakuhin KK filed Critical Otsuka Kagaku Yakuhin KK
Publication of DE2218162A1 publication Critical patent/DE2218162A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DE19722218162 1971-04-14 1972-04-14 Entzündungshemmende Mittel Pending DE2218162A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2400571A JPS5443074B1 (https=) 1971-04-14 1971-04-14

Publications (1)

Publication Number Publication Date
DE2218162A1 true DE2218162A1 (de) 1972-11-02

Family

ID=12126433

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19722218162 Pending DE2218162A1 (de) 1971-04-14 1972-04-14 Entzündungshemmende Mittel

Country Status (3)

Country Link
JP (1) JPS5443074B1 (https=)
DE (1) DE2218162A1 (https=)
GB (1) GB1390542A (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4120971A (en) 1977-03-01 1978-10-17 Merck & Co., Inc. Novel N-carboxy-alpha-amino acid anhydrides
EP0045285A1 (en) * 1980-07-01 1982-02-03 Etablissement TEXCONTOR Non absorbable compounds of mucolytic activity, the process for their preparation and therapeutic compositions which contain them as active principle
DE3315482A1 (de) * 1982-04-30 1984-01-12 Kaken Pharmaceutical Co., Ltd., Tokyo Mittel zur verhinderung und behandlung von blutlipid-abnormalitaet und/oder arteriosclerose
WO2014037438A1 (en) * 2012-09-05 2014-03-13 Novozymes A/S Polypeptides having protease activity

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ277766B6 (en) * 1990-01-04 1993-04-14 Vnii Textilno Biologically active material and process for preparing thereof
GB0123232D0 (en) * 2001-09-26 2001-11-21 Smith & Nephew Polymers
DE10321725A1 (de) * 2003-05-14 2004-12-02 Mucos Pharma Gmbh & Co Enzymhaltige Zusammensetzungen, daraus hergestellte diätetische Lebensmittel und Arzneimittel und ihre Verwendung für medizinische Zwecke
US7998476B2 (en) 2006-11-22 2011-08-16 Standard Biologics, Inc. Method of treatment using Aspergillus oryzae protease
JP2011507867A (ja) 2007-12-19 2011-03-10 イーエルシー マネージメント エルエルシー トラメテス属の抽出物を用いた皮膚処置用組成物および方法
CN114224980A (zh) * 2020-09-08 2022-03-25 上海市同仁医院 一种外用涂抹组合物

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4120971A (en) 1977-03-01 1978-10-17 Merck & Co., Inc. Novel N-carboxy-alpha-amino acid anhydrides
EP0045285A1 (en) * 1980-07-01 1982-02-03 Etablissement TEXCONTOR Non absorbable compounds of mucolytic activity, the process for their preparation and therapeutic compositions which contain them as active principle
DE3315482A1 (de) * 1982-04-30 1984-01-12 Kaken Pharmaceutical Co., Ltd., Tokyo Mittel zur verhinderung und behandlung von blutlipid-abnormalitaet und/oder arteriosclerose
WO2014037438A1 (en) * 2012-09-05 2014-03-13 Novozymes A/S Polypeptides having protease activity

Also Published As

Publication number Publication date
GB1390542A (en) 1975-04-16
JPS5443074B1 (https=) 1979-12-18

Similar Documents

Publication Publication Date Title
US3969540A (en) Enzymatically prepared metal proteinates
CA1106306A (en) Process for the production of xylose by enzymatic hydrolysis of xylan
DE3874119T2 (de) Verfahren zur enzymatischen herstellung von oligodextranen, verwendbar bei der produktion von ersatzmitteln fuer zucker, und diese oligodextrane.
DE69232731T2 (de) Medizinische Zusammensetzungen
DE1944048C3 (de) Verfahren zur Herstellung eines wasserlöslichen Enzymsystems
DE2218162A1 (de) Entzündungshemmende Mittel
DE2347782B2 (de) Aminozuckerderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE431139T1 (de) Lösliche diätfaserzusammensetzungen aus hafer.
DE2646879A1 (de) Matrix aus einem in wasser unloeslichen beta-1,3-glucangel und verfahren zu ihrer herstellung
EP0003616A2 (de) Neue Aminozucker-Derivate, ihre Herstellung und Amylase-hemmende Mittel
DE2247163A1 (de) Traegermatrix zur fixierung biologisch wirksamer stoffe und verfahren zu ihrer herstellung
DE3633292A1 (de) Pharmazeutische zusammensetzung
DE1943490A1 (de) Enzymatisch aktives Addukt und Verfahren zu seiner Herstellung
DE2659808B2 (de) Proteingebundene Polysaccharide und deren Verwendung zur Bekämpfung von Tumoren
DE3017372A1 (de) Physiologisch aktive polysaccharide, verfahren zu ihrer herstellung sowie ihre verwendung
DE2218148A1 (de) Entzündungshemmendes Mittel und Ver fahren zur Herstellung desselben
JP3519187B2 (ja) 免疫力増強物質及びその製造方法
DE3124429A1 (de) Proteolytisches mittel fuer proteinhydrolysen
JPH02100695A (ja) 難消化性デキストリンの製造法
DE2417265A1 (de) Traegergebundene enzyme
DE69029061T2 (de) Antihypertonika und Lebensmittel und Getränke, die solche Antihypertonika enthalten
DE2614393B2 (de) Aminozucker-Derivate und diese Verbindungen enthaltende Arzneimittel
EP0499306B1 (en) Starches with an improved flavour
DE1948298A1 (de) Stabile,Polymer-Enzym-Verbindungen enthaltende Mundhygiene-Mittel
DE2828933A1 (de) 3- eckige klammer auf (s)-1'-phenylaethylamino eckige klammer zu -propylaminobleomycin, verfahren zu seiner herstellung und diese verbindung enthaltendes arzneimittel